Left Atrial Appendage Closure Device
Trusted Safety. Proven Efficacy. No Compromises.
Built on the most studied and implanted LAAC device in the world — WATCHMAN FLX™ is the leader in LAAC therapy. WATCHMAN FLX offers proven safety, unmatched procedural simplicity and excellent seal to help ensure optimal device performance.
WATCHMAN FXD Curve™ Access System
The WATCHMAN FXD Curve™ Access System is designed for the WATCHMAN FLX™ LAAC device, bringing smoother deployment and successful placement to the delivery of the most studied and implanted LAAC device in the world.
Learn More About WATCHMAN FLX
*Complete LAA occlusion defined as no visible peri-device leak (PDL) and absence of contrast patency in the distal LAA (LAA/left atrium Hounsfield ratio <0.25).
- Kar S, et al. Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial. Circulation. 2021;143:1754-1762.
- Procedural safety events in the PINNACLE FLX trial is defined as the occurrence of one of the following events between the time of implant and within 7 days after the procedure or by hospital discharge, whichever was later: death, ischemic stroke, systemic embolism, or device or procedure-related events requiring open cardiac surgery or major endovascular intervention.
- Lakkireddy, Primary Outcomes of the Amplatzer™ Amulet™ IDE Randomized Controlled Trial, Presented as an abstract at the European Society of Cardiology Congress, August 30, 2021.
- Procedural complications in the Amulet IDE is defined as adverse events which are adjudicated as procedure-related and require either an invasive surgical or percutaneous intervention.
- Galea. SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure, TCT 2021.
- Major procedure-related complications for this trial were defined as as composite of death, cerebrovascular event, systemic embolism, major bleeding (BARC 3-5), clinically relevant pericardial effusion, device embolization, or acute kidney injury occurring within 7 days or thereafter if deemed procedure-related.
- Reddy VY, et al. JACC 2017; 70(24): 2964-2975.